mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.03 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.03 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.04 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |